The New York Times: Clinical trials of the Corona vaccine have...

The cyber attacks on the healthcare sector caused a lot of inconvenience and problems. The New York Times reported that clinical trials slowed after a company was exposed to eResearchTechnology The healthcare provider to ransomware attacks two weeks ago, and they were both IQVIA It is a research company that runs a vaccine business COVID-19 Affiliated to a company AstraZeneca , side by side Bristol Myers Squibb Leading an alliance is developing a test COVID-19 Quick, one of the biggest goals.

She said both IQVIA And Bristol Myers Squibb The impact of the attack was “limited,” thanks in part to data backups. eResearchTechnology Others had to track down trial patients using paper, and it is not clear if the malware affected any trials of COVID-19.

It is not certain who is behind the ransomware, nor is it mentioned eResearchTechnology Whether it paid the ransom to restore its computers.

This news comes just days after a massive suspected ransom campaign was launched against Universal Health Services Patient care was hampered. Weeks ago, a German patient died when digital ransom demands forced a hospital to transport a patient in need of vital care.

Ransomware appears to hit health care systems deeper, and they have a tangible effect on these systems at a time when they are needed more than ever before.

It is worth noting that a joint announcement issued by the National Center for Cyber ​​Security in the United Kingdom, the Communications Security Corporation in Canada and the National Security Agency in the United States last July revealed details of the Russian government employing the cybercrime group “Cozy Bear” (APT29) to target medical institutions operating On developing a vaccine for Covid-19 disease within those three countries.